Arteris, Inc. (NASDAQ:AIP – Get Free Report) COO Laurent R. Moll sold 1,161 shares of Arteris stock in a transaction on Monday, January 6th. The stock was sold at an average price of $12.52, for a total value of $14,535.72. Following the transaction, the chief operating officer now directly owns 450,600 shares of the company’s stock, valued at approximately $5,641,512. This represents a 0.26 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink.
Arteris Stock Performance
Shares of Arteris stock opened at $11.25 on Thursday. Arteris, Inc. has a 1 year low of $4.83 and a 1 year high of $12.64. The company has a debt-to-equity ratio of 0.30, a current ratio of 1.16 and a quick ratio of 1.16. The business has a 50 day moving average price of $9.16 and a 200 day moving average price of $8.13. The company has a market capitalization of $451.99 million, a P/E ratio of -11.72 and a beta of 1.17.
Analysts Set New Price Targets
Separately, Rosenblatt Securities reaffirmed a “buy” rating and set a $15.00 price target on shares of Arteris in a research note on Wednesday, November 6th.
Hedge Funds Weigh In On Arteris
Institutional investors have recently made changes to their positions in the stock. US Bancorp DE acquired a new stake in shares of Arteris during the third quarter valued at $34,000. The Manufacturers Life Insurance Company purchased a new position in Arteris in the 2nd quarter valued at about $86,000. Algert Global LLC acquired a new stake in shares of Arteris during the 2nd quarter worth about $115,000. MetLife Investment Management LLC grew its holdings in shares of Arteris by 129.1% during the third quarter. MetLife Investment Management LLC now owns 16,951 shares of the company’s stock worth $131,000 after buying an additional 9,551 shares in the last quarter. Finally, Dynamic Technology Lab Private Ltd acquired a new position in shares of Arteris in the third quarter valued at approximately $226,000. 64.36% of the stock is owned by institutional investors and hedge funds.
About Arteris
Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.
Recommended Stories
- Five stocks we like better than Arteris
- Utilities Stocks Explained – How and Why to Invest in Utilities
- Why AMD Stock Might Already Be This Year’s Best Buy
- What is a Stock Market Index and How Do You Use Them?
- 3 Promising Penny Stocks to Watch for Long-Term Gains in 2025
- REIT Stocks – Best REIT Stocks to Add to Your Portfolio Today
- The 3 Kings of Buybacks in 2024: Can They Do It Again?
Receive News & Ratings for Arteris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arteris and related companies with MarketBeat.com's FREE daily email newsletter.